Biofeedback and AI teletherapy to improve speech clarity
Biofeedback-Enhanced Treatment for Sensorimotor Learning in Speech Sound Disorders: Clinical Trial and Delineation of Subtypes
Using visual biofeedback and AI-supported teletherapy to help children and adults with lasting speech sound problems speak more clearly.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10983357 on NIH RePORTER |
What this research studies
If you join, you would receive speech therapy that shows visual feedback of your speech (for example, acoustic displays or tongue imaging) and may use AI tools to guide practice. The team will deliver treatment remotely by telepractice and compare different ways of using biofeedback to see which helps the most. They will also group participants into subtypes of speech sound disorder to match people with the treatments most likely to help them. Treatment effects will be measured by changes in speech clarity and practical communication outcomes.
Who could benefit from this research
Good fit: Children, adolescents, and adults who have persistent residual speech sound disorder (speech sounds that remain unclear despite prior development or therapy) and who can participate in teletherapy are ideal candidates.
Not a fit: People whose speech problems are primarily due to severe hearing loss, neuromotor disorders (like dysarthria or apraxia of speech), or who cannot use teletherapy technology may not benefit from this approach.
Why it matters
Potential benefit: If successful, this could improve speech clarity for people with persistent speech sound disorders and make effective biofeedback treatment available to more families through teletherapy and AI support.
How similar studies have performed: Previous smaller trials and the investigators' earlier work showed that visual-acoustic and ultrasound biofeedback can improve speech sound production, but wider use via AI and telehealth remains under study.
Where this research is happening
New York, United States
- New York University — New York, United States (Active)
Researchers
- Principal investigator: Mcallister, Tara — New York University
- Study coordinator: Mcallister, Tara
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.